THE ANDALUSIAN PUBLIC FOUNDATION FOR THE BIOMEDICAL RESEARCH IN MALAGA (FIMABIS), LOCATED IN MALAGA, SPAIN, INVITES QUALIFIED EXPERIENCED RESEARCHER TO EXPRESS THEIR INTEREST FOR A POSTDOCTORAL POSITION TO COORDINATE THE UNIT OF CLINICAL RESEARCH AND CLINICAL TRIALS” OF THE BIOMEDICAL RESEARCH INSTITUTE OF MALAGA(IBIMA)
UICEC
Principal investigator:
Maria Isabel Lucena.
Center:
IBIMA/ Hospital Universitario Virgen de la Victoria
Functions
- Methodological advice and support to Clinical trials
- Evaluation of Clinical Trials
- Design of Protocols and running of Clinical Trials Phase I & II
- Pharmacovigilance tasks and elaboration of reports
Essential Criteria
- PhD in Medicine or Pharmacy
- Experience in the Evaluation of Clinical Trials
- Experience in Drug Regulatory Affairs
- Experience in Protocols and Clinical Trials Phase I & II
- Experience in Pharmacovigilance tasks and elaboration of reports
- High level of English (written and spoken)
- At least 3 years relevant research experience
- Must have published paper(s) in quality journals
- Evidence of proactive organisational capabilities
- Ability to assess and organise resources
- Ability to communicate complex information clearly
- Ability to build contacts and participate in internal and external networks and research presentations
- Use of office packages, especially Excel, as well as databases
- Team worker, highly motivated, supportive of colleagues within the group
Desirable Criteria
- Training in Clinical Pharmacology
- Experience in the Development of Clinical Trials
- Experience in Methodological advice and support to Clinical trials
- Experience in Regulatory & GCP in Clinical research
Application details
All the applications will be sent
(with the following reference REF: MIL1POST1802 to the following email
rrhh@ibima.eu
Deadline: February, 28th 2014. 15.00 pm.
Deadline: March, 25th 2014. 15.00 pm. Extended April, 25th 2014. 15.00 pm
Selection process
After the selection of the best CVs, the candidates will be interviewed
Descargar en PDF
co-funded by the European Fund for Regional Development (FEDER)